Watch our on-demand webinar!

Post-transplant monitoring: The future of chimerism testing.

Insight and inspiration

News IVDR | March 1, 2023

We have launched our first IVDR-certified product

Today we launched our first IVDR-certified product. Devyser Compact is a rapid genetic test for prenatal chromosome testing and the first of its type to be approved under the new more comprehensive regulation that came into force in May 2022. The original product was first launched in 2006 and is today the golden standard in prenatal testing in many European countries.

Find out more

Webinar on-demand | February 16, 2023

Post-transplant monitoring: The future of chimerism testing

News | January 25-26, 2023

We are attending the Festival of Genomics & Biodata!

Podcast | December 6, 2022

Collaborations and homebrew assays by Dan Hauzenberger & Turid Sundin Carlsson

Latest from the Devyser blog

View all

New more sensitive diagnostics protect transplanted kidney

With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...

Early relapse prediction after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia (ALL) using lineage-specific chimerism analysis

Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for patients with...

Assessment of Chimerism Testing by Next Generation Sequencing

Relapse of the underlying malignant disease is a major complication after hematopoietic stem cell...